Firm Logo
215-608-9645

Holly Dolejsi

Partner

Office Locations

60 South 6th St, Suite 2800Minneapolis, MN 55402P: (651) 376-2872
130 N 18th St #1600Philadelphia, PA 19103P: (215) 929-8822

Holly brings nearly fifteen years’ experience representing those injured by the negligence and misdeeds of corporations. She has represented hundreds of individuals harmed by defective medical devices and pharmaceuticals. In addition to advocating for her individual clients, Holly has also served in leadership roles in various cases, where she advocated on behalf of all plaintiffs. She was appointed as Co-Lead Counsel of the Farxiga MDL (In re Farxiga (Dapagliflozin) Products Liability Litigation, MDL No. 2776), and appointed to the Plaintiff’s Steering Committee of the Invokana MDL (In Re: Invokana (Canagliflozin) Product Liability Litigation, MDL No. 2750).

In addition to representing injured individuals, she also has represented cities, counties, and Native American tribes in their public nuisance claims against the manufacturers, distributors, and pharmacies in the chain of distribution of prescription opioids. (In Re: National Prescription Opiate Litigation, MDL No. 2804, Case No. 17-md-02804.) Holly’s role in these cases was recognized by Minnesota Lawyer, which awarded her Lawyer of the Year for 2022.

Holly served as outside counsel for the State of Minnesota in its public nuisance claims against JUUL and Altria for Minnesota’s youth vaping epidemic. For her role on that case team, including a critical role on the trial team, she again was awarded Minnesota Layer’s Attorney of the Year Award for a second consecutive year.

Currently, in addition to representing our clients in their claims against Uber and Lyft in the Passenger Sexual Assault MDL and JCCP, she also is active on the Expert and Discovery committees. She is also a central part of the team representing survivors of childhood sexual assault while detailed as juveniles. She represents clients in state and federal court who have been injured by eating baby food contaminated with toxic heavy metals, as well as infants harmed by baby formula. Her work at Walsh Law continues to further her passion for helping others.

In addition to her work on behalf of her clients, Holly has shown consistent advocacy for the advancement of women in the legal field. Perhaps most significantly, she co-founded the Women Trial Lawyer Conference, an annual conference for women plaintiff lawyers in Minnesota. At the conference, women participate in networking, skills trainings, and education, with a goal of fostering a network that supports women in the law and helps them advance in their chosen field. In addition to co-founding the conference, Holly sits on the conference planning committee. This work resulted in her receiving the “Member of the Year” award from Minnesota Association for Justice in 2018.

Holly also has devoted substantial time to pro bono matters. She’s represented dozens of transgender and non-binary individuals in obtaining legal name and gender marker changes. More recently, she’s taken on the role of pro bono counsel to World Without Genocide, a non-profit dedicated to protecting the lives of innocent people and prevention of future genocide. Holly has demonstrated again and again her commitment to fairness, justice, and the dignity and humanity of all persons through her pro bono work, and her work on behalf of injured individuals and municipalities.

When not at work, Holly enjoys spending time with her husband, family, and friends. She enjoys all the wonderful cuisine and cultural opportunities that Minneapolis and St. Paul have to offer, but also loves quiet time spent reading a good book or game night with friends.

Practice Areas

  • Mass Torts

Admissions

  • Minnesota - 10/30/2009
  • United States District Court, D. Minn - 12/1/2011
  • United States District Court, Central District of IL - 12/5/2014

Awards & Accolades

  • Named a “Minnesota Super Lawyer,” by Super Lawyers (2023)
  • Listed in “500 Leading Plaintiff Consumer Lawyers” List, Lawdragon (2023, 2024)
  • Named an “Attorney of the Year,” Minnesota Lawyer (2022, 2023)
  • Named a “North Star Lawyer” by the Minnesota State Bar Association for providing at least 50 hours of pro bono legal services (2022)
  • Legal Council on Legal Diversity Fellow (2021)
  • Recipient of Minnesota Lawyer’s Diversity and Inclusion Award (2020)
  • Named a “Member of the Year,” Minnesota Association for Justice (2018)
  • Named an “UP & Coming Attorney,” Minnesota Lawyer (2017)
  • Named to the “Top 40 Under 40” list, The National Trial Lawyers (2015)
  • Named a “Minnesota Rising Star,” Super Lawyers (2015-2019)

Education

  • William Mitchell College of Law, J.D. magna cum laude (2009)
  • Northwestern University, B.A. (2003)

Associations & Memberships

  • American Bar Association
  • Federal Bar Association
  • Law360 Product Liability Editorial Advisory Board (2022-2023)
  • Minnesota Association for Justice
  • American Association for Justice
  • The American Lawyer, Young Lawyer Editorial Board

Articles & Publications

  • The Robins Kaplan Justice Report, "Robins Kaplan Pursuing Camp Lejeune Claims" (January 2023)
  • Holly Dolejsi - The Robins Kaplan Justice Report, "Purdue Bankruptcy – Opioid Update" (Spring 2021)
  • Holly Dolejsi - The Robins Kaplan Justice Report, "COVID Immunity: No, Not That Kind of Immunity" (Fall 2020)

Representative Cases

  • State of Minnesota v. Juul Labs, Inc. et al., Case No. 27-CV-19-19888: Represented the State of Minnesota in litigation against e-cigarette manufacturer JUUL and Altria for their alleged role in Minnesota’s youth vaping epidemic. Culminated in multi-week trial and $60.5 million settlement.
  • In Re: National Prescription Opiate Litigation, MDL No. 2804, Case No. 17-md-02804: Represented 28 Tribal Nations and 17 California cities and counties in their claims against the manufacturers, distributors, and dispensing pharmacies related to the opioid epidemic.
  • In re Farxiga (Dapagliflozin) Products Liability Litigation, MDL No. 2776: Served as Co-Lead Counsel of the Farxiga Multidistrict Litigation.
  • In Re: Invokana (Canagliflozin) Product Liability Litigation, MDL No. 2750: Served on the Plaintiffs’ Steering Committee of the Invokana Multidistrict litigation.